CUMMINGS KEITH LAMONT (Chief Financial Officer) received a stock award from PLIANT THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/31/2023ACC: 0001209191-23-021917
Officer· Chief Financial Officer
Since Jun 2020
+19.38K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
19.38K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+19.38K
Price / share
—
Trade value
—
% of position
13.9%
3/29/2023
139.06K→158.43K
Total
Net shares
+19.38K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/29/2023 | A · Award | +19.38K | — | — | 13.9% | 139.06K | 158.43K |
| Total | +19.38K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported